Loading
Total declarations
Company
▲ Purchases (18 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Feb 2024 for Emmaus Life Sciences, Inc., €1,464. Read the official filing
Filing timeline
BuySaleWillis C. Lee
Insider track record
Disclosed buys
18
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-24.5%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Willis C. Lee: trading record in brief
Willis C. Lee is a declared insider of Emmaus Life Sciences, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 18 filings cover trades dated from 5 May 2021 to 26 February 2024.
The open-market record is one-sided, with 18 purchases worth €63k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at 2 purchases and no sales.
A typical purchase (the median) is worth €1,599. On 12 out of 18 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 29 February 2024: an open-market purchase of €1,464, in Emmaus Life Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Willis C. Lee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
13,200 shares@ US$0.121.3% of flowCommon stock, $0.001 par valueSEC:0001209191-24-004124:0
Canonical exit: 26 May 2024 (T+90)
6,500 shares@ US$0.211.1% of flowCommon stock, $0.001 par valueSEC:0001209191-24-000442:0
Canonical exit: 23 Nov 2023 (T+90)
1,365 shares@ US$0.210.2% of flowCommon stock, $0.001 par valueSEC:0001209191-23-057328:0
Canonical exit: 23 Nov 2023 (T+90)
750 shares@ US$0.280.2% of flowCommon stock, $0.001 par valueSEC:0001209191-23-033573:0
Canonical exit: 19 Dec 2022 (T+90)
3,200 shares@ US$0.391.0% of flowCommon stock, $0.001 par valueSEC:0001209191-22-043081:0
Canonical exit: 17 Oct 2022 (T+90)
2,500 shares@ US$0.370.11% mcap0.8% of flowCommon stock, $0.001 par valueSEC:0001209191-22-033847:0
Canonical exit: 25 Aug 2022 (T+90)
3,200 shares@ US$0.980.35% mcap2.5% of flowCommon stock, $0.001 par valueSEC:0001209191-22-024129:0
Canonical exit: 3 Jul 2022 (T+90)
500 shares@ US$1.420.078% mcap0.6% of flowCommon stock, $0.001 par valueSEC:0001209191-22-013725:0
Canonical exit: 23 May 2022 (T+90)
500 shares@ US$1.540.084% mcap0.6% of flowCommon stock, $0.001 par valueSEC:0001209191-22-001426:0
Canonical exit: 3 Mar 2022 (T+90)
24,328 shares@ US$1.4550.2% of flowCommon stock, $0.001 par valueSEC:0001209191-21-067167:0
Canonical exit: 24 Feb 2022 (T+90)
3,500 shares@ US$1.326.6% of flowCommon stock, $0.001 par valueSEC:0001209191-21-066920:0
Canonical exit: 21 Feb 2022 (T+90)
1,600 shares@ US$1.242.8% of flowCommon stock, $0.001 par valueSEC:0001209191-21-066428:0
Canonical exit: 13 Feb 2022 (T+90)
2,000 shares@ US$1.514.1% of flowCommon stock, $0.001 par valueSEC:0001209191-21-056785:0
Canonical exit: 14 Dec 2021 (T+90)
2,000 shares@ US$1.704.6% of flowCommon stock, $0.001 par valueSEC:0001209191-21-055547:0
Canonical exit: 7 Dec 2021 (T+90)
2,400 shares@ US$1.514.9% of flowCommon stock, $0.001 par valueSEC:0001209191-21-053681:0
Canonical exit: 23 Nov 2021 (T+90)
2,700 shares@ US$1.535.4% of flowCommon stock, $0.001 par valueSEC:0001209191-21-036627:0
Canonical exit: 24 Aug 2021 (T+90)
1,500 shares@ US$1.142.2% of flowCommon stock, $0.001 par valueSEC:0001209191-21-032183:0
Canonical exit: 8 Aug 2021 (T+90)
2,500 shares@ US$1.264.2% of flowCommon stock, $0.001 par valueSEC:0001209191-21-030990:0
Canonical exit: 3 Aug 2021 (T+90)
18 of 18 declarations
